Inhibition of human myometrial activity by a new beta-adrenergic drug (DU-21220).
D002245:Carbon Dioxide / Q000097:blood; D002319:Cardiovascular System / Q000187:drug effects; D003864:Depression, Chemical; D005260:Female; D005333:Fetus; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007743:Labor, Obstetric; D008365:Manometry; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D013566:Sympathomimetics / Q000008:administration & dosage*; D014599:Uterus / Q000187:drug effects*
D013566:Sympathomimetics; D002245:Carbon Dioxide